HUTCHMED (China) (HCM) Income from Non-Controlling Interests (2018 - 2021)
HUTCHMED (China) (HCM) posted quarterly Income from Non-Controlling Interests of -$27.6 million for Q4 2021, down 2042.87% quarter-over-quarter from -$1.3 million in Q1 2021.
HUTCHMED (China) (HCM) Income from Non-Controlling Interests (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Income from Non-Controlling Interests for 4 consecutive years, with -$27.6 million the latest figure, recorded in Q4 2021.
- In Q4 2021, Income from Non-Controlling Interests changed N/A year-over-year to -$27.6 million; the TTM figure through Dec 2021 stood at -$30.4 million (changed N/A YoY), while the FY2025 annual figure was -$105818.5, down 87.23% from the prior year.
- Income from Non-Controlling Interests slipped to -$27.6 million in Q4 2021 per HCM's latest filing, from -$1.3 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $3.9 million in Q2 2018 and bottomed at -$27.6 million in Q4 2021.
- Historically, Income from Non-Controlling Interests has averaged -$2.4 million across 4 years, with a median of -$644500.0 in 2019.
- Annual changes were most pronounced in 2019 — Income from Non-Controlling Interests soared 158.79% — and 2020, when it slumped 191.78%.
- HUTCHMED (China)'s Income from Non-Controlling Interests stood at $788000.0 in 2018, then tumbled by 172.84% to -$574000.0 in 2019, then dropped by 27.7% to -$733000.0 in 2020, then slumped by 3671.21% to -$27.6 million in 2021.
- Business Quant data shows HCM's Income from Non-Controlling Interests at -$27.6 million in Q4 2021, -$1.3 million in Q1 2021, and -$733000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 376,434.15 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | HUTCHMED (China) | 2.17 Bn | 2.17 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -27.64 Mn |
| Mar 31, 2021 | -1.29 Mn |
| Jun 30, 2020 | -733,000.00 |
| Mar 31, 2020 | -715,000.00 |
| Dec 31, 2019 | -574,000.00 |
| Sep 30, 2019 | 143,000.00 |
| Jun 30, 2019 | -2.69 Mn |
| Mar 31, 2019 | 779,000.00 |
| Dec 31, 2018 | 788,000.00 |
| Sep 30, 2018 | 165,000.00 |
| Jun 30, 2018 | 3.89 Mn |
| Mar 31, 2018 | -1.33 Mn |